We are live on ! Find out more
IVLAV

Index Venture Life Associates VI Portfolio holdings

AUM $396M
1-Year Est. Return 176.22%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+176.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$143M
AUM Growth
-$23.8M
Cap. Flow
-$190K
Cap. Flow %
-0.13%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IPSC icon
Century Therapeutics
IPSC
+$190K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$143M 100%
9,961,789
IPSC icon
2
Century Therapeutics
IPSC
$355M
-188,251
Closed -$190K

Similar funds

Index Venture Life Associates VI's Q1 2025 Portfolio in Review

As of Q1 2025, Index Venture Life Associates VI held 2 positions worth $143M, down 14% from $167M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Index Venture Life Associates VI's Q1 2025 filing shows 1 closed position. The largest sale was Century Therapeutics, an estimated $190K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Index Venture Life Associates VI fully exited Century Therapeutics in Q1 2025, selling an estimated $190K.
  • Index Venture Life Associates VI's ten largest holdings make up 100% of its $143M portfolio in Q1 2025.
  • Index Venture Life Associates VI opened 0 new positions and closed 1 in Q1 2025.
  • Index Venture Life Associates VI's portfolio value fell 14% quarter-over-quarter to $143M.

Based on Index Venture Life Associates VI's 13F filing for Q1 2025, filed 15 May 2025.